BIOADAPTIVES, INC. (BDPT) › Cash & EquivalentsBIOADAPTIVES, INC. (BDPT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $18.6K2014: $37.9K2015: $992018: $56.2K2019: $12.3K2020: $4.6K2021: $82.9K2022: $82.9K2023: $88.6K2024: $261.9K2025: $215.2K$215.2K2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$215.2K-17.8%2024$261.9K+195.7%2023$88.6K+6.8%2022$82.9K+0.0%2021$82.9K+1708.1%2020$4.6K-62.7%2019$12.3K-78.1%2018$56.2K—2015$99-99.7%2014$37.9K+103.5%2013$18.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share